These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 10650672

  • 1. [IgA nephropathy and intrahepatic percutaneous portosystemic shunt].
    Blanco Sampascual S, de las Heras Niño B, Marcé Landeta L, Orive Cura V.
    Gastroenterol Hepatol; 1999 Dec; 22(10):535-6. PubMed ID: 10650672
    [No Abstract] [Full Text] [Related]

  • 2. Hepatic encephalopathy after liver transplantation in a patient with a normally functioning graft: Treatment with embolization of portosystemic collaterals.
    Herrero JI, Bilbao JI, Diaz ML, Alegre F, Inarrairaegui M, Pardo F, Quiroga J.
    Liver Transpl; 2009 Jan; 15(1):111-4. PubMed ID: 19109845
    [No Abstract] [Full Text] [Related]

  • 3. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
    Fernandes PF, Júnior GB, Barros FA, Sousa DC, Franco LM, Patrocínio RM.
    Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
    [Abstract] [Full Text] [Related]

  • 4. Studies of IgA nephropathy in renal transplantation.
    Suganuma T, Morozumi K, Satoh K, Yosida A, Fujinami T, Uchida K, Yamada N, Orihara A, Tanaka Y, Shinmura I.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2123-7. PubMed ID: 2652686
    [No Abstract] [Full Text] [Related]

  • 5. [Hemolysis associated with intrahepatic percutaneous portosystemic shunt].
    Pérez Roldan F, Rodríguez Laíz JM, Casado M, Bañares R, Lago M, Clemente G, Echenagusía A, Camúñez F, Cos E.
    Gastroenterol Hepatol; 1995 Apr; 18(4):169-71. PubMed ID: 16541562
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Transjugular intrahepatic portosystemic shunt before hepatic surgery in a patient with cirrhosis and portal hypertension: case report].
    Chalret Du Rieu M, Carrere N, Bureau C, Lagarde S, Otal P, Pradere B.
    J Chir (Paris); 2009 Apr; 146(2):191-4. PubMed ID: 19535077
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of prior portosystemic shunt procedures on outcome of liver transplantation.
    Dell'Era A, Grande L, Barros-Schelotto P, Turnes J, Fuster J, Charco R, García-Valdecasas JC, Bosch J, García-Pagán JC.
    Surgery; 2005 Jun; 137(6):620-5. PubMed ID: 15933628
    [Abstract] [Full Text] [Related]

  • 10. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y.
    Clin Transplant; 2005 Jun; 19 Suppl 14():41-8. PubMed ID: 15955168
    [Abstract] [Full Text] [Related]

  • 11. Influence of a prior porta-systemic shunt on outcome after liver transplantation.
    Langnas AN, Marujo WC, Stratta RJ, Donovan JP, Sorrell MF, Rikkers LF, Shaw BW.
    Am J Gastroenterol; 1992 Jun; 87(6):714-8. PubMed ID: 1590306
    [No Abstract] [Full Text] [Related]

  • 12. Cerebral edema and hyperammonemia after transjugular intrahepatic portosystemic shunt placement in a cirrhotic patient.
    Kavitt RT, Yang VL, Jensen DM.
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1054-6. PubMed ID: 18603480
    [Abstract] [Full Text] [Related]

  • 13. Portosystemic shunt via the superior mesenteric and right ovarian vein leading to small intestine bleeding in alcoholic liver cirrhosis.
    Vamadevan S, Haltmeier T, Groebli Y.
    BMJ Case Rep; 2013 Mar 18; 2013():. PubMed ID: 23513021
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of refractory hydrothorax with intrahepatic portosystemic shunt in the course of primary biliary cirrhosis].
    Bechade D, Blanc JF, Lescene R, Drouillard J, Oddes B.
    Gastroenterol Clin Biol; 1998 Mar 18; 22(8-9):743-5. PubMed ID: 9823569
    [No Abstract] [Full Text] [Related]

  • 15. Membranoproliferative glomerulonephritis with IgA deposits in patients with alcoholic cirrhosis.
    Ferrario G, Palazzi P, Torri Tarelli L, Volpi A, Meroni M, Giordano F, Sessa A.
    Pathologica; 1986 Mar 18; 78(1056):469-78. PubMed ID: 3615024
    [No Abstract] [Full Text] [Related]

  • 16. Renal graft outcome in simultaneous kidney transplantation combined with other organs: experience of a single center.
    Gutierrez-Baños J, Portillo J, Ballestero R, Zubillaga S, Ramos E, Campos J, Hidalgo E.
    Transplant Proc; 2008 Dec 18; 40(10):3424-7. PubMed ID: 19100404
    [Abstract] [Full Text] [Related]

  • 17. Vasculitic IgA nephropathy: prognosis and outcome.
    Pankhurst T, Lepenies J, Nightingale P, Howie AJ, Adu D, Harper L.
    Nephron Clin Pract; 2009 Dec 18; 112(1):c16-24. PubMed ID: 19342865
    [Abstract] [Full Text] [Related]

  • 18. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 Dec 18; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 19. Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome.
    Bachet JB, Condat B, Hagège H, Plessier A, Consigny Y, Belghiti J, Valla D.
    J Hepatol; 2007 Jan 18; 46(1):60-8. PubMed ID: 17107735
    [Abstract] [Full Text] [Related]

  • 20. Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation.
    Coppo R, Amore A, Chiesa M, Lombardo F, Cirina P, Andrulli S, Passerini P, Conti G, Peruzzi L, Giraudi R, Messina M, Segoloni G, Ponticelli C.
    Clin Transplant; 2007 Jan 18; 21(6):728-37. PubMed ID: 17988266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.